Patents by Inventor Wing L. Sung

Wing L. Sung has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8927248
    Abstract: A modified Family 11 xylanase enzyme comprising cysteine residues at positions 99 and 118 to form an intramolecular disulfide bond is provided. The modified xylanase is produced by substitution of an amino acid at position 99, 118 or both positions 99 and 118 with a cysteine to produce the intramolecular disulfide bond. Xylanases of the invention display improved thermophilicity, alkalophilicity or thermostability relative to wild-type xylanases. Such xylanases find use in a variety of applications in industry that require enzyme activities at temperatures and/or pH values above that of the native enzyme.
    Type: Grant
    Filed: October 17, 2008
    Date of Patent: January 6, 2015
    Assignee: National Research Council Canada
    Inventor: Wing L. Sung
  • Patent number: 8603802
    Abstract: A method of extracting fibers from decorticated plant bast skin involves pre-treating decorticated plant bast skin of a fiber plant with an aqueous solution containing trisodium citrate having a pH in a range of about 8-14 at a temperature of about 90° C. or less; and subsequently treating recovered fibers with a protease at alkaline pH.
    Type: Grant
    Filed: December 23, 2009
    Date of Patent: December 10, 2013
    Assignee: National Research Council of Canada
    Inventors: Wing L. Sung, Mark Wood, Fang Huang
  • Patent number: 8591701
    Abstract: A method of extracting hemp fibers from decorticated hemp bast skin involves pre-treating the decorticated hemp bast skin with an aqueous solution containing di-sodium citrate, tri-sodium citrate or a mixture thereof having a pH of from about 6-13 at temperature of about 90° C. or less; and subsequently treating recovered fiber with a enzyme. Determining the extent of completion of a plant fiber degumming process involves treating degummed fiber with a recombinant pectinase expressed in an organism that produces neither cellulose nor xylanase, to release reducing sugar from any residua pectin on the degummed fiber, and, quantifying the released reducing sugar.
    Type: Grant
    Filed: May 14, 2007
    Date of Patent: November 26, 2013
    Assignee: National Research Council of Canada
    Inventors: Wing L. Sung, Mark Wood, Fang Huang
  • Publication number: 20110312066
    Abstract: A method of extracting fibers from decorticated plant bast skin involves pre-treating decorticated plant bast skin of a fiber plant with an aqueous solution containing trisodium citrate having a pH in a range of about 8-14 at a temperature of about 90° C. or less; and subsequently treating recovered fibers with a protease at alkaline pH.
    Type: Application
    Filed: December 23, 2009
    Publication date: December 22, 2011
    Inventors: Wing L. Sung, Mark Wood, Fang Huang
  • Publication number: 20100147472
    Abstract: A method of extracting hemp fibers from decorticated hemp bast skin involves pre-treating the decorticated hemp bast skin with an aqueous solution containing di-sodium citrate, tri-sodium citrate or a mixture thereof having a pH of from about 6-13 at temperature of about 90° C. or less; and subsequently treating recovered fiber with a enzyme. Determining the extent of completion of a plant fiber degumming process involves treating degummed fiber with a recombinant pectinase expressed in an organism that produces neither cellulose nor xylanase, to release reducing sugar from any residua pectin on the degummed fiber, and, quantifying the released reducing sugar.
    Type: Application
    Filed: May 14, 2007
    Publication date: June 17, 2010
    Inventors: Wing L. Sung, Mark Wood, Fang Huang
  • Patent number: 7695947
    Abstract: The present invention pertains to modified xylanase enzymes that exhibit increased thermostability and alkalophilicity, when compared with their native counterparts. Several modified xylanases exhibiting these properties are disclosed including xylanases with at least one modification at amino acid position 10, 27, 29, 75, 104, 105, 125, 129, 132, 135, 144, 157, 161, 162 or 165, or a combination thereof. Also included within the present invention is a modified xylanase that comprises at least one substituted amino acid residue and that may be characterized as having a maximum effective temperature (MET) between about 69° C. and about 78° C., wherein the modified xylanase is a Family 11 xylanase obtained from a Trichoderma sp. The present invention also includes a modified Family 11 xylanase obtained from a Trichoderma sp. characterized as having a maximum effective pH (MEP) between 5.8 and about 7.6. Modified xylanases characterized as having a MET between about 69° C. and about 78° C.
    Type: Grant
    Filed: March 17, 2006
    Date of Patent: April 13, 2010
    Assignee: National Research Council of Canada
    Inventor: Wing L. Sung
  • Publication number: 20090325267
    Abstract: The present invention pertains to modified xylanase enzymes that exhibit increased thermostability and alkalophilicity, when compared with their native counterparts. Several modified xylanases exhibiting these properties are disclosed including xylanases with at least one modification at amino acid position 10, 27, 29, 75, 104, 105, 125, 129, 132, 135, 144, 157, 161, 162 or 165, or a combination thereof. Also included within the present invention is a modified xylanase that comprises at least one substituted amino acid residue and that may be characterized as having a maximum effective temperature (MET) between about 69° C. and about 78° C., wherein the modified xylanase is a Family 11 xylanase obtained from a Trichoderma sp. The present invention also includes a modified Family 11 xylanase obtained from a Trichoderma sp. characterized as having a maximum effective pH (MEP) between 5.8 and about 7.6. Modified xylanases characterized as having a MET between about 69° C. and about 78° C.
    Type: Application
    Filed: March 17, 2006
    Publication date: December 31, 2009
    Inventor: Wing L. Sung
  • Publication number: 20090148923
    Abstract: A modified Family 11 xylanase enzyme comprising cysteine residues at positions 99 and 118 to form an intramolecular disulfide bond is provided. The modified xylanase is produced by substitution of an amino acid at position 99, 118 or both positions 99 and 118 with a cysteine to produce the intramolecular disulfide bond. Xylanases of the invention display improved thermophilicity, alkalophilicity or thermostability relative to wild-type xylanases. Such xylanases find use in a variety of applications in industry that require enzyme activities at temperatures and/or pH values above that of the native enzyme.
    Type: Application
    Filed: October 17, 2008
    Publication date: June 11, 2009
    Inventor: Wing L. SUNG
  • Patent number: 7510860
    Abstract: The present invention provides a xylanase, or a modified xylanase enzyme comprising at least one substituted amino acid residue at a position selected from the group consisting of amino acid 11, 116, 118, 144 and 161, the position determined from sequence alignment of the modified xylanase with Trichoderma reesei xylanase II amino acid sequence. The xylanases described herein exhibit improved thermophilicity, alkalophilicity, expression efficiency, or a combination thereof, in comparison to a corresponding native xylanase.
    Type: Grant
    Filed: November 21, 2001
    Date of Patent: March 31, 2009
    Assignee: National Research Council of Canada
    Inventor: Wing L. Sung
  • Publication number: 20090075330
    Abstract: The present invention provides a xylanase, or a modified xylanase enzyme comprising at least one substituted amino acid residue at a position selected from the group consisting of amino acid 11, 116, 118, 144 and 161, the position determined from sequence alignment of the modified xylanase with Trichoderma reesei xylanase II amino acid sequence. The xylanases described herein exhibit improved thermophilicity, alkalophilicity, expression efficiency, or a combination thereof, in comparison to a corresponding native xylanase.
    Type: Application
    Filed: November 21, 2001
    Publication date: March 19, 2009
    Inventor: Wing L. Sung
  • Patent number: 7060482
    Abstract: The present invention is directed to thermostable xylanase enzymes are suitable for feed pelleting applications. The novel xylanase enzymes comprise at least 40% of their optimal activity from a pH range from about pH 3.5 to about pH 6.0, and from about 40 to about 60° C., and exhibit at least 30% of their optimal activity after a pre-incubation step for 30 minutes at 70° C. in the presence of 40% glycerol. Also disclosed are modified xylanase molecules comprising either a basic amino acid at position 162 (TrX numbering), or its equivalent position in other xylanase molecules, at least one disulfide bridge, or a combination thereof. The thermostable xylanase molecules of the present invention have a physiological temperature and pH optima and are useful as animal feeds additives since they can withstand the heat associated with feed sterilization and pellet formation, yet they exhibit optimal activity within an animal to aid in breakdown of ingested feed.
    Type: Grant
    Filed: November 16, 1999
    Date of Patent: June 13, 2006
    Assignee: National Research Council of Canada
    Inventors: Wing L. Sung, Jeffrey S. Tolan
  • Publication number: 20030166236
    Abstract: The present invention pertains to modified xylanase enzymes that exhibit increased thermostability and alkalophilicity, when compared with their native counterparts. Several modified xylanases exhibiting these properties are disclosed including xylanases with at least one modification at amino acid position 10, 27, 29, 75, 104, 105, 125, 129, 132, 135, 144, 157, 161, 162, or 165, or a combination thereof. Also included within the present invention is a modified xylanase that comprises at least one substituted amino acid residue and that may be characterized as having a maximum effective temperature (MET) between about 69° C. and about 78° C., wherein the modified xylanase is a Family 11 xylanase obtained from a Trichoderma sp.. The present invention also includes a modified Family 1p1 xylanase obtained from a Trichoderma sp. characterized as having a maximum effective pH (MEP) between about 5.8 and about 7.6. Modified xylanases characterized as having a MET between about 69° C.
    Type: Application
    Filed: December 2, 2002
    Publication date: September 4, 2003
    Inventor: Wing L. Sung
  • Patent number: 5866408
    Abstract: Producing a xylanase enzyme of superior performance in the bleaching of pulp. More specifically, a modified xylanase of Family 11 that shows improved thermophilicity, alkalophilicity, and thermostability as compared to the natural xylanase. The modified xylanases contain any of three types of modifications: (1) changing amino acids 10, 27, and 29 of Trichoderma reesei xylanase II or the corresponding amino acids of another Family 11 xylanase, where these amino acids are changed to histidine, methionine, and leucine, respectively; (2) substitution of amino acids in the N-terminal region with amino acids from another xylanase enzyme. In a preferred embodiment, substitution of the natural Bacillus circulans or Trichoderma reesei xylanase with a short sequence of amino acids from Thermomonospora fusca xylanase yielded chimeric xylanases with higher thermophilicity and alkalophilicity; (3) an extension upstream of the N-terminus of up to 10 amino acids.
    Type: Grant
    Filed: March 25, 1998
    Date of Patent: February 2, 1999
    Assignee: National Research Council of Canada
    Inventors: Wing L. Sung, Makoto Yaguchi, Kazuhiko Ishikawa
  • Patent number: 5759840
    Abstract: Producing a xylanase enzyme of superior performance in the bleaching of pulp. More specifically, a modified xylanase of Family 11 that shows improved thermophilicity, alkalophilicity, and thermostability as compared to the natural xylanase. The modified xylanases contain any of three types of modifications: (1) changing amino acids 10, 27, and 29 of Trichoderma reesei xylanase II or the corresponding amino acids of another Family 11 xylanase, where these amino acids are changed to histidine, methionine, and leucine, respectively; (2) substitution of amino acids in the N-terminal region with amino acids from another xylanase enzyme. In a preferred embodiment, substitution of the natural Bacillus circulans or Trichoderma reesei xylanase with a short sequence of amino acids from Thermomonospora fusca xylanase yielded chimeric xylanases with higher thermophilicity and alkalophilicity; (3) an extension upstream of the N-terminus of up to 10 amino acids.
    Type: Grant
    Filed: September 9, 1996
    Date of Patent: June 2, 1998
    Assignee: National Research Council of Canada
    Inventors: Wing L. Sung, Makoto Yaguchi, Kazuhiko Ishikawa
  • Patent number: 5556940
    Abstract: Certain analogues of human parathyroid hormone (hPTH) have been found to be effective for the treatment of osteoporosis, while showing decreased side effects. Analogues showing this effect include all sequences from hPTH-(1-28)-NH.sub.2 to hPTH-(1-31)-NH.sub.2 and all sequences from [Leu.sup.27 ]-hPTH-(1-28)-NH.sub.2 to [Leu.sup.27 ]-hPTH-(1-33)-NH.sub.2. Also included are cyclic analogues cyclo(Lys.sup.26 -Asp.sup.30) [Leu.sup.27 ]-hPTH-(1-34)NH.sub.2 and cyclo (Lys.sup.27 -Asp.sup.30 )-hPTH-(1-34)-NH.sub.2. Analogues in the form of the carboxyl terminal amide are particularly effective.
    Type: Grant
    Filed: June 20, 1994
    Date of Patent: September 17, 1996
    Assignee: National Research Council of Canada
    Inventors: Gordon E. Willick, James F. Whitfield, Witold Surewicz, Wing L. Sung, Witold Neugebauer
  • Patent number: 5405769
    Abstract: The thermostability of the 20,396 dalton Bacillus circulans xylanase was increased by site-directed mutagenesis. The thermostability was conferred by the presence of non-native disulfide bridges, and selected N-terminal mutations. The introduction of these non-native disulfide bridges was accomplished by the examination of the three-dimensional structure of the enzyme, and choosing sites where a favorable geometry for a bridge existed. The N-terminal mutations were constructed on the basis of primary sequence comparison with other family G xylanases. The mutant proteins were examined for their ability to retain enzymatic activity after heating as an indication of increased thermostability. These thermotolerant variants are useful as an alternative to chemical bleaching of Kraft pulp in a pre-bleaching step (bio-bleaching). The pre-bleaching involves temperatures higher than that normally used for these enzymes and accordingly these thermotolerant variants can be advantageously used at this step.
    Type: Grant
    Filed: April 8, 1993
    Date of Patent: April 11, 1995
    Assignee: National Research Council of Canada
    Inventors: Robert L. Campbell, David R. Rose, Wing L. Sung, Makoto Yaguchi, Warren W. Wakarchuk
  • Patent number: 5021337
    Abstract: A process is described for monitoring the production of recombinant proteins. It is based on the discovery that infrared spectra of E. coli strains and transformants which overproduce recombinant proteins can be measured as a function of pressure, and a pressure-induced distinct shifting pattern can be observed in specific spectral parameters of transformants. In particular, the difference in the pressure-induced shift of the amide III band, between the E. coli cells and the transformants over-producing the recombinant proteins provides an efficient and non-intrusive technique for on-line monitoring of the production of recombinant proteins in E. coli.
    Type: Grant
    Filed: July 15, 1988
    Date of Patent: June 4, 1991
    Assignee: National Research Council of Canada
    Inventors: Patrick T. T. Wong, Saran A. Narang, Wing L. Sung